Cargando…
Biopsy Procedures and Molecular Testing Utilization and Related Costs in Patients with Metastatic Lung Cancer
BACKGROUND: Epidermal growth factor receptor (EGFR) gene mutations and anaplastic lymphoma kinase (ALK) gene rearrangements are key therapeutic targets for biomarker-driven treatment with an EGFR or ALK tyrosine kinase inhibitor (TKI) in patients with metastatic non-small cell lung cancer (NSCLC). T...
Autores principales: | Shinde, Reshma, Cao, Xiting, Kothari, Smita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397943/ https://www.ncbi.nlm.nih.gov/pubmed/27668568 http://dx.doi.org/10.18553/jmcp.2016.15404 |
Ejemplares similares
-
Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)
por: McArthur, Grant A., et al.
Publicado: (2017) -
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
por: Lee, Dae Ho, et al.
Publicado: (2018) -
Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan
por: Isobe, Hiroshi, et al.
Publicado: (2017) -
Invasive Diagnostic Procedures from Bronchoscopy to Surgical Biopsy—Optimization of Non-Small Cell Lung Cancer Samples for Molecular Testing
por: Lalić, Nensi, et al.
Publicado: (2023) -
Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma
por: Shen, Chan, et al.
Publicado: (2022)